A B O U T U S
Neuroplast is a Dutch clinical stage stem cell technology company with a European Orphan Designation, focusing on fast-track development programs. Neuroplast develops autologous stem cell treatments to improve and extend the lives of people who suffer from primarily inflammation-driven neurological disorders, that pressure healthcare expenditure, when no other treatments are available.
Neuroplast Neuro-Cells® is classified as an Advanced Therapy Medicinal Product (ATMP) tissue engineered product by the European Medicine Agency (EMA). Neuro-Cells® is produced under the ATMP Good Manufacturing Practice (GMP) guidelines and in a fully GMP certified production facility in Geleen, The Netherlands.